Clinical trial
Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
NCT05499832 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Intra-arterial Tenecteplase for Noncomplete Reperfusion of Intracranial Occlusions
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 21, 2023
- Completion date
- October 9, 2025
- Enrollment
- 156 (actual)
- Sites
- 52
Conditions
As the registry lists them; a condition with its own page is linked.